Halo Labs Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 15

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $35.1M

Halo Labs General Information

Description

Developer of an early commercial-stage scientific platform designed to deliver unprecedented insights into the particles present in the research processes. The company's platform focuses on developing and commercializing throughput biopharmaceutical quality control tools using the latest optics, image processing, and microfluidics, enabling researchers to learn more about the stability and quality of their biological drugs with accuracy.

Contact Information

Formerly Known As
Optofluidics
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 1828 El Camino Real
  • Suite 703
  • Burlingame, CA 94010
  • United States
+1 (800)
Primary Industry
Discovery Tools (Healthcare)
Parent Company
Corporate Office
  • 1828 El Camino Real
  • Suite 703
  • Burlingame, CA 94010
  • United States
+1 (800)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Halo Labs Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Merger/Acquisition 20-May-2025 $35.1M Completed Generating Revenue
10. Later Stage VC (Series C) 29-Dec-2022 Completed Generating Revenue
9. Later Stage VC (Series B1) 06-Apr-2020 Completed Generating Revenue
8. Later Stage VC (Series B) 10-Dec-2018 Completed Generating Revenue
7. Grant 01-Jan-2018 Completed Generating Revenue
6. Later Stage VC (Series A) 01-May-2017 Completed Generating Revenue
5. Seed Round 05-Jun-2015 Completed Generating Revenue
4. Seed Round 13-Jun-2014 Completed Generating Revenue
3. Seed Round 08-Nov-2013 $750K Completed Startup
2. Seed Round 26-Jun-2012 $750K $750K Completed Startup
To view Halo Labs’s complete valuation and funding history, request access »

Halo Labs Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C
Series B1
Series B 2,044,300 $0.001000 8% $3 $3 1x $3 23.39%
Series A 621,841 $0.001000 8% $2.74 $2.74 1x $2.74 7.12%
To view Halo Labs’s complete cap table history, request access »

Halo Labs Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an early commercial-stage scientific platform designed to deliver unprecedented insights into the particles
Discovery Tools (Healthcare)
Burlingame, CA
15 As of 2025

San Jose, CA
 

Frederick, MD
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Halo Labs Competitors (6)

One of Halo Labs’s 6 competitors is Molecular Devices, a Corporate Backed or Acquired company based in San Jose, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Molecular Devices Corporate Backed or Acquired San Jose, CA
Lifeline Cell Technology Corporate Backed or Acquired Frederick, MD
Miltenyi Biotec Private Debt Financed Bergisch Gladbach, Germany
MatTek Corporate Backed or Acquired Ashland, MA
iXCells Biotechnologies Private Equity-Backed San Diego, CA
To view Halo Labs’s complete competitors history, request access »

Halo Labs Patents

Halo Labs Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-12456315-B2 Methods for distinguishing particles in a fluid sample Active 16-Aug-2021
US-20250349137-A1 Methods for distinguishing particles in a fluid sample Pending 16-Aug-2021
WO-2023023033-A1 Methods for distinguishing particles in a fluid sample Inactive 16-Aug-2021
WO-2019210025-A1 Vacuum manifold for filtration microscopy Inactive 25-Apr-2018
CA-3014099-A1 System and method for characterizing particulates in a fluid sample Inactive 18-Feb-2016 G02B21/367
To view Halo Labs’s complete patent history, request access »

Halo Labs Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Halo Labs Former Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds
Agilent Technologies Corporation Minority
Ben Franklin Technology Partners of Central and Northern Pennsylvania Accelerator/Incubator Minority
Ben Franklin Technology Partners of Southeastern Pennsylvania Accelerator/Incubator Minority
BioAdvance Capital (Conshohocken) Venture Capital Minority
BroadOak Capital Partners Growth/Expansion Minority
You’re viewing 5 of 16 investors. Get the full list »

Halo Labs FAQs

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process